Filter
364
Filtered Results: 364
Text search:
National
Pharmacovigilance
Policy
Featured
Recommendations
41
New Publications
130
Language
Document type
No document type
207
Guidelines
57
Studies & Reports
45
Strategic & Response Plan
20
Manuals
18
Fact sheets
7
Training Material
5
Situation Updates
4
Infographics
1
Countries / Regions
Kenya
21
Nigeria
15
Ghana
14
Uganda
14
India
14
Western and Central Europe
13
Rwanda
11
Global
11
Eastern Europe
11
Nepal
10
South Africa
10
Namibia
9
Ethiopia
8
Sierra Leone
7
Malawi
7
Tanzania
6
Philippines
5
Congo, Democratic Republic of
5
South–East Asia Region
5
Liberia
5
Africa
4
Cambodia
4
West and Central Africa
4
Bangladesh
4
Russia
4
Zambia
4
Lesotho
3
Benin
3
Senegal
3
Zimbabwe
3
Mozambique
3
Latin America and the Carribbean
3
East and Southern Africa
3
Botswana
3
Ukraine
2
Syria
2
Haiti
2
Asia
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Sudan
2
Libya
2
Indonesia
2
Myanmar / Burma
2
Madagascar
2
Eswatini/ Swaziland
2
Pakistan
2
Thailand
1
Gambia
1
Cameroon
1
Laos
1
Burkina Faso
1
Afghanistan
1
Guinea
1
Jordan
1
Western Pacific Region
1
Maldives
1
Lebanon
1
Sri Lanka
1
Yemen
1
Georgia
1
Mali
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Drugs & Medical Equipment
65
Policies
58
Policies & Guidelines HIV & TB
37
Guidelines
34
Studies & Reports
18
Women & Child Health
10
TB
10
Malaria
9
NTDs & Others
8
Statistics
6
Pharmacy & Technology
5
COVID-19
4
Countries
4
Non-communicable Diseases
4
HIV & STI
4
Disease Prevention & Control
4
Communicable Diseases
3
Hepatitis
3
Vaccine-preventable Diseases
3
Community Health
3
Capacity Building
3
Taeniasis/ Cysticercosis
2
Snakebites
2
Pharmaceutical Assessments
2
NCD
2
Medical Devices & Equipment
2
Immunization
2
General Guidelines
2
Leprosy
2
Paediatrics
1
Clinical Training
1
Rabies
1
Helminthiasis
1
Under-5 nutrition
1
Disaster Preparedness
1
Trachoma
1
Onchocerciasis
1
Schistosomiasis
1
Dermatology
1
Lymphaticfilariasis
1
Cancer
1
Vector Control
1
Community Health
1
Pediatric cancer
1
Non-communicable Diseases NCD
1
Public Health
1
Pediatrics
1
Cardiovascular Diseases
1
Clinical Guidelines
1
Demograhic Health Surveys DHS
1
Other
1
Respiratory Infections
1
Communicable Diseases
1
Health Systems
1
Maternal Health
1
Primary Health Care
1
Dengue
1
Leishmaniasis
1
Laboratory Quality Assurance
1
Key Resources
1
Global Health
1
Pharmacy & Technologies
1
Toolboxes
Country specific
15
Rational use of Medicine
11
Drug resistant TB
11
Access & Strategy
8
Pharmacovigilance
8
Reports & Studies
7
Essential Medicines
6
Falsified & Substandard
5
Traditional & Herbal Medicines
5
Antiretroviral Treatment ART
5
Clinical Aspects, Treatment & Prevention
4
Clinical Guidelines
4
Supporting tools
4
Country Specific
4
Immunization Guidelines
4
Eastern Europe & Central Asia
4
SEAR (South-east Asia Region)
4
Adults
3
Hospital Readiness/Essential Health Services
3
Inactivated COVID-19 Vaccines
3
Essential Medicines & Devices Lists
3
General Guidelines for Rational Use
3
Overview, Studies & Reports
3
Research & Access
3
Western & Central Europe
3
Treatment & Prevention
2
Preparedness, Response & Risk Communication
2
Prevention & Control
2
Children & Adolescents
2
WPRO (Western Pacific Region)
2
Children
2
Georgia
2
Drug resistance
2
Ethiopia
2
International
2
Prevention & Preparedness
2
Studies
2
General
2
Oxygen Therapy
2
Logistics & Supply
2
Prices and Patents
2
Pharmaceutical Assessments
2
Pharmacy Practice
2
One Health
2
Waste Managment
2
Studies & Reports
2
Education of students & professionals
2
Uganda
2
HIV service delivery
2
Reports & Studies
2
Eastern Europe and central Asia
2
Outbreak Prevention & Control
1
Clinical Guidelines
1
Childhood TB
1
Agriculture & Veterinary
1
Clinical Guidelines
1
Azerbaijan
1
Clinical Aspects
1
Vaccination
1
Ukraine
1
South Africa
1
Influenza
1
Treatment Guidelines HIV
1
Namibia
1
Public Health
1
HIV
1
Prevention & Control
1
Rwanda
1
Research
1
Vaccination
1
TB & Other Vulnerable Populations
1
Country Guidelines
1
Belarus
1
Reports
1
Russia
1
Health Personnel
1
Infection Control General
1
Surveillance & Contact tracing
1
For Pregnant Women
1
Training, others
1
Appeals and Response Plans
1
Gender Aspects
1
Communication Material
1
TB/HIV
1
Fair Allocation & Ethical Aspects
1
COVAX Initiative
1
Biontech/Pfizer Comirnaty
1
Vaxzevria (Astra Zeneca)
1
Johnson & Johnson
1
Standard Operating Procedure (SOP)
1
Midwives
1
Pharmacy Management
1
Quality Assurance
1
Antimicrobial Resistance (AMR)
1
Waste management
1
Leishmaniasis
1
Capacity Building & Resources
1
Clinical Aspects & Diagnostics
1
Statistics & Facts
1
Statistics & Facts
1
Studies & Reports
1
Patient Safety
1
Clinical Aspects & Diagnosis
1
Clinical Aspects & Diagnosis
1
Prevention & Strategies
1
Clinical Aspects & Diagnosis
1
Diagnosis
1
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
1
Romania
1
Asia and Pacific
1
Co-Morbidities (except TB)
1
Neurological Disorders
1
General Aspects
1
Human Rights & the Right to Health
1
TB & Prisoners
1
Training
1
General Public
1
TB/HIV Coinfection
1
Clinical Guidelines
1
Kazakhstan
1
AmR (Region of Americas)
1
TB
1
Reports & Studies Children HIV
1
Kenya
1
Meningitis & Encephalitis
1
Preparedness & Prevention
1
Treatment & Clinical Management
1
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
STATUTORY INSTRUMENTS | SUPPLEMENT No. 8 28th March, 2014 | STATUTORY INSTRUMENTS SUPPLEMENT | to The Uganda Gazette No. 18 Volume CVII dated 28th March, 2014 | Printed by UPPC, Entebbe, by Order of the Government. | STATUTORY INSTRUMENTS | 2014 No. 37.
Antimicrobial resistance (AMR) is a major public health challenge, which is recognized as high priority area by the Government of India. The increasing consumption of antibiotics is one of the key drivers of antimicrobial resistance seen in bugs of public health importance. Irrational prescription o...
These guidelines for the National Pharmacovigilance and Medicine Information System in Rwanda have been developed to ensure that safe, efficacious and quality medicines are made available to all Rwandans.
The safety of medicines in Zambia - why health workers need to take action | Produced by the National Pharmacovigilance Unit (NPVU)
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
The purpose of these guidelines is to help health workers to participate in the process of continuous surveillance of safety and efficacy of the pharmaceutical products which are used in clinical practice, thus help to achieve the ultimate goal to make safer and more effective treatment available to...
Apart from implementation of TB infection Prevention and Control measures, treatment of those with active TB of the lungs is key in preventing the spread of the TB bacilli. The Public Health Act CAP 242, section 17 classify TB as notifiable infectious disease and under section 26 as part of preventi...
Towards a Healthier Botswana
Therapeutics Information and Pharmacovigilance Centre | TIPC
